Analyze Diet
Cureus2024; 16(4); e57638; doi: 10.7759/cureus.57638

The Management of Xylazine Overdose With Naloxone.

Abstract: This article discusses a rare case of isolated xylazine overdose in a human, treated successfully with naloxone. Xylazine, typically used as a veterinary tranquilizer, acts as a potent α2 adrenergic agonist, leading to sedation, muscle relaxation, and potential respiratory depression. In this case, a female mistakenly injected herself with xylazine mistaking it for a different medication. The report discusses naloxone's role beyond opioid overdose, especially regarding substances causing central nervous system (CNS) depression via mechanisms similar to those of opioids. While naloxone is traditionally associated with opioid receptor antagonism, its successful application here suggests potential benefits against non-opioid substances such as xylazine. The report emphasizes the need for higher naloxone dosages than those used for opioid toxicity and suggests more research into its use for treating xylazine intoxication, reflecting on the growing trend of xylazine as a recreational drug adulterant and the resulting health risks.
Publication Date: 2024-04-05 PubMed ID: 38707050PubMed Central: PMC11070055DOI: 10.7759/cureus.57638Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is about a unique case of a human overdosing on xylazine, a veterinary tranquilizer, which was successfully treated with naloxone, and reflects on the potential uses of naloxone beyond treating opioid overdoses.

About the Case

  • The research discusses a rare case where a woman accidentally injected herself with xylazine, mistaking it for a different medication. Xylazine is an α2 adrenergic agonist which is normally used as a veterinary tranquilizer, producing effects like sedation, muscle relaxation, and potentially dangerous respiratory depression.

Treatment with Naloxone

  • The woman was successfully treated with naloxone, a medication generally associated with treating opioid overdoses. Xylazine causes central nervous system (CNS) depression in a manner similar to opioids, therefore, naloxone was found to be effective against its toxic effects.
  • The study underscores the need for larger doses of naloxone to counteract xylazine overdose as compared to opioids toxicity.

Implications for Future Research

  • This case highlights the potential for naloxone to be used against non-opioid substances that are similar to xylazine. Therefore, the study suggests the need for more in-depth research on naloxone’s application for treating xylazine intoxication.
  • The paper also emphasizes the rising problem of xylazine being used as an additive in recreational drugs, which poses new health risks. Hence, this case helps to raise awareness about this growing issue and points towards the need for more comprehensive options for managing such cases.

Conclusion

  • The successful use of naloxone to treat a xylazine overdose points to its potential use beyond opioid antidote. Further research is required to establish guidelines for naloxone usage and dosage in treatment of non-opioid substance intoxication like xylazine.

Cite This Article

APA
Morris J, Hoang D. (2024). The Management of Xylazine Overdose With Naloxone. Cureus, 16(4), e57638. https://doi.org/10.7759/cureus.57638

Publication

ISSN: 2168-8184
NlmUniqueID: 101596737
Country: United States
Language: English
Volume: 16
Issue: 4
Pages: e57638
PII: e57638

Researcher Affiliations

Morris, James
  • Emergency Medicine, Texas Tech University Health Sciences Center School of Medicine, Lubbock, USA.
Hoang, Dustin
  • Emergency Medicine, Texas Tech University Health Sciences Center School of Medicine, Lubbock, USA.

Conflict of Interest Statement

The authors have declared that no competing interests exist.

References

This article includes 7 references
  1. Hoffman RS. Closing the xylazine knowledge gap.. Clin Toxicol (Phila) 2023;61:1013–1016.
    pubmed: 38270058
  2. Hoffmann U, Meister CM, Golle K, Zschiesche M. Severe intoxication with the veterinary tranquilizer xylazine in humans.. J Anal Toxicol 2001;25:245–249.
    pubmed: 11386637
  3. North DS, Wieland MJ, Peterson CD, Krenzelok EP. Naloxone administration in clonidine overdosage.. Ann Emerg Med 1981;10:397.
    pubmed: 7247102
  4. Ruiz-Colón K, Chavez-Arias C, Díaz-Alcalá JE, Martínez MA Martínez MA. Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature.. Forensic Sci Int 2014;240:1–8.
    pubmed: 24769343
  5. Feigenbaum JJ, Howard SG. The effect of naloxone on spontaneous and evoked dopamine release in the central and peripheral nervous systems.. Life Sci 1996;59:2009–2019.
    pubmed: 8950303
  6. Choon LK, Khiruddin AI, Annuar WM, Shamsuddin SR. A case series of accidental xylazine intoxication in humans; is there a role of naloxone as an antidote?. Turk J Emerg Med 2023;23:119–122.
    pmc: PMC10166292pubmed: 37169031
  7. Seger DL, Loden JK. Naloxone reversal of clonidine toxicity: dose, dose, dose.. Clin Toxicol (Phila) 2018;56:873–879.
    pubmed: 29544366

Citations

This article has been cited 2 times.
  1. Sandhu KS, Kumar S, Garg K, Aggarwal K, Tiwwary M, Perry G, Bansal V, Jain R. The xylazine-fentanyl nexus: A public health emergency. SAGE Open Med 2025;13:20503121251348068.
    doi: 10.1177/20503121251348068pubmed: 40546932google scholar: lookup
  2. Owusu-Antwi P, Atodaria P, Appiah-Kubi E, Shah Z, Garcia EM. Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review. Am J Addict 2025 Nov;34(6):589-602.
    doi: 10.1111/ajad.70051pubmed: 40476542google scholar: lookup